Abstract
The substrate recognition regions in cytochrome P450 family 2 (CYP2) proteins were inferred by group-to-group alignment of CYP2 sequences and those of bacterial P450s, including Pseudomonas putida P450 101A (P450cam), whose substrate-binding residues have been definitely identified by x-ray crystallography of a substrate-bound form (Poulos T. L., Finzel, B. C., and Howard, A. J. (1987) J. Mol. Biol. 195, 687-700). The six putative substrate recognition sites, SRSs, thus identified are dispersively located along the primary structure and constitute about 16% of the total residues. All the reported point mutations and chimeric fragments that significantly affect the substrate specificities of the parental CYP2 enzymes fell within or overlapped some of the six SRSs. Analysis of nucleotide substitution patterns in closely related members in four subfamilies, CYP2A, 2B, 2C, and 2D, consistently indicated that the SRSs have accumulated more nonsynonymous (amino acid-changing) substitutions than the rest of the sequence. This observation supports the idea that diversification of duplicate genes of drug-metabolizing P450s occurs primarily in substrate recognition regions to cope with an increasing number of foreign compounds.
Highlights
The substrate recognition regionsin cytochrome P450 family 2(CYP2) proteins were inferred by group-to-group alignment of CYP2 sequences and those of bacterial P450s, including Pseudomonas putidu P450 l O l A (P450,), whose substrate-binding residues have been definitely identifiedby x-ray crystallography of a substrate-bound form
It is of great interest to elucidate the molecular mechanisms underlying the broad but specific metabolic capacities of the mammalian P450 systems consisting of relatively limited numbers of catalysts
This paper presents potential substrate recognition sites in mammalian P450s identified using an amended alignment
Summary
The substrate recognition regionsin cytochrome P450 family 2(CYP2) proteins were inferred by group-to-group alignment of CYP2 sequences and those of bacterial P450s, including Pseudomonas putidu P450 l O l A (P450,,,), whose substrate-binding residues have been definitely identifiedby x-ray crystallography of a substrate-bound form All the reported point mutations and chimeric fragments that significantly affect the substrate specificities of the parental CYPB enzymes fell within oroverlapped some of the six SRSs. Analysis of nucleotide substitution patterns in closely related members in four subfamilies, CYPSA, 2B, 2C, and 2D, consistently indicated that the SRSs have accumulated more nonsynonymous (amino acid-changing) substitutions than the rest of the sequence. Analysis of nucleotide substitution patterns in closely related members in four subfamilies, CYPSA, 2B, 2C, and 2D, consistently indicated that the SRSs have accumulated more nonsynonymous (amino acid-changing) substitutions than the rest of the sequence This observation supports the idea that diversification of duplicate genes of drug-metabolizing P450s occurs primarily in substrate recognition regions to cope with an increasing number of foreign compounds. It is of great interest to elucidate the molecular mechanisms underlying the broad but specific metabolic capacities of the mammalian P450 systems consisting of relatively limited numbers of catalysts
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
